← Back to patent-cliff list
Vornorexant
Tier C — Watch / tradeVornorexant
-
Originator
2025
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：OX2R, OX1R
Brand：Vorzzz, ボルズィ
Indications (approved)：Insomnia and sleep disorders
Regional status
US
No progress
2020-09-14
EU
-
China
-
Japan
Approved
2025-08-25
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Vornorexant?
Approved indications include: Insomnia and sleep disorders.
When does the Vornorexant patent expire?
No public expiry year is available for Vornorexant yet; this page updates once verified.
How do I get a quote for Vornorexant intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01